(a) Give an account of ultrastructure of rough and smooth endoplasmic reticulum. Also discuss the role of endoplasmic reticulum…

(a) Ultrastructure of Rough and Smooth ER; Role in Cell Secretion

The endoplasmic reticulum (ER) exists as two morphologically and functionally distinct domains: the rough endoplasmic reticulum (RER) and the smooth endoplasmic reticulum (SER). Ultrastructurally, the RER comprises an extensive network of parallel, flattened, membrane-delimited saccules termed cisternae. The cytosolic surface of the RER membrane is studded with 80S ribosomes bound via translocon complexes and ribophorins I and II, enclosing a continuous luminal space. In contrast, the SER consists of a convoluted, three-dimensional meshwork of interconnected tubules devoid of membrane-bound ribosomes, maintaining continuity with the RER and with the outer nuclear membrane. RER is abundant in protein-secreting cells such as pancreatic acinar cells and plasma cells, whereas SER dominates in steroid-secreting cells (adrenal cortex, Leydig cells), in hepatocytes, and as the sarcoplasmic reticulum that stores Ca²⁺ in muscle.

The ER plays a pivotal role in cellular secretion through an integrated biosynthetic pathway. Secretory proteins bearing an N-terminal hydrophobic signal peptide are recognized by the Signal Recognition Particle (SRP) and translocated cotranslationally into the RER lumen. Within the lumen, molecular chaperones like BiP (Binding immunoglobulin Protein) and calnexin ensure proper protein folding and disulfide bond formation, while oligosaccharyltransferase initiates core N-linked glycosylation. Misfolded proteins are exported and degraded via ER-associated degradation (ERAD). Correctly folded secretory proteins are packaged into COPII-coated transport vesicles that bud from ER exit sites and fuse with the cis-Golgi network for post-translational modification, sorting, and eventual exocytic release. Concurrently, the SER facilitates secretion by synthesizing membrane lipids, lipoproteins, and steroid hormones, while also housing cytochrome P450 monooxygenases for metabolic detoxification.

(b) Heterochromatin versus Euchromatin: Structure and Function

Nuclear chromatin is compartmentalized into euchromatin and heterochromatin, reflecting dynamic states of gene expression:

Structurally, euchromatin exists in a relaxed, decondensed 10 to 30 nm nucleosomal fiber conformation during interphase. It replicates early in the S-phase and is characterized by hyperacetylated histones and hypomethylated DNA. Functionally, euchromatin is transcriptionally active, allowing access to RNA polymerase II and transcription factors. Examples include ubiquitously expressed housekeeping genes, such as GAPDH and actin, as well as developmentally inducible genes.

Heterochromatin remains highly condensed and cytologically dense throughout interphase. It replicates late in the S-phase and exhibits epigenetic marks such as histone H3 lysine 9 trimethylation (H3K9me3) and hypermethylated DNA, rendering it transcriptionally silent. It is categorized into two forms:

• Constitutive heterochromatin remains permanently silenced across all cell types, serving structural roles at centromeres and telomeres to maintain chromosomal integrity.
• Facultative heterochromatin possesses the capacity to alternate between condensed and relaxed states depending on developmental signals. A classic mammalian example is dosage compensation via X-chromosome inactivation (lyonization), where one female X-chromosome condenses into a transcriptionally inert Barr body.

(c) Signal Molecules and Pathological Effects of Signalling Defects

Signal molecules, or ligands, are chemical entities that mediate intercellular communication via endocrine, paracrine, autocrine, or juxtacrine modes. Hydrophilic signals act on cell-surface receptors (G-protein-coupled receptors, receptor tyrosine kinases, ligand-gated ion channels), whereas lipophilic signals such as steroids and thyroid hormones cross the membrane and bind intracellular receptors that act as transcription factors. They include peptide hormones (insulin, glucagon), steroid hormones (estrogen, cortisol), growth factors (EGF, FGF), cytokines (interleukins), and neurotransmitters (acetylcholine, dopamine).

Defects occurring at distinct nodes of signaling cascades disrupt cellular homeostasis, generating severe pathological conditions:

First, receptor mutations and overexpression lead to aberrant downstream firing. Gain-of-function mutations in the Epidermal Growth Factor Receptor (EGFR) drive continuous cell survival and proliferation in non-small cell lung carcinomas and glioblastomas.

Second, dysregulation of heterotrimeric G-proteins disrupts intracellular second messengers. For example, the Vibrio cholerae enterotoxin covalently modifies the Gαs subunit via ADP-ribosylation, locking it in an active state; this causes sustained adenylate cyclase activation, hyper-elevated cAMP, and severe secretory diarrhea. Conversely, Bordetella pertussis toxin inactivates Gαi, impairing immune clearance.

Third, intracellular kinase cascades are frequently mutated in malignancies. Constitutive activation of the Ras-Raf-MEK-MAPK pathway due to K-Ras mutations bypasses normal growth checkpoints. In India, this pathway is frequently implicated in the high incidence of oral squamous cell carcinoma (OSCC), where betel quid and tobacco carcinogens induce mutations in EGFR, Ras, and cyclin D1 networks.

Other classic examples are insulin-receptor signalling defects in insulin resistance and type 2 diabetes, loss-of-function androgen-receptor mutations causing androgen insensitivity syndrome, growth hormone receptor defects in Laron dwarfism, and the BCR–ABL fusion kinase of chronic myeloid leukaemia, which is targeted by imatinib.